Related Experiment Videos
Circulating interferon-alpha in patients with Kyasanur forest disease
P S Sathe1, C N Dandawate, K Sharadamma
1National Institute of Virology, Pune.
The Indian Journal of Medical Research
|July 1, 1991
Summary
Kyasanur Forest Disease (KFD) patients show high levels of endogenous interferon (IFN) during the acute phase, which decrease significantly by the convalescent phase. This interferonemia correlates with the viremic period and appears similar to IFN-alpha.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Kyasanur Forest Disease (KFD) is a tick-borne viral hemorrhagic fever endemic to India.
- Understanding the host immune response, particularly interferon dynamics, is crucial for KFD pathogenesis.
- Previous studies have not fully elucidated the role of endogenous interferon during KFD infection.
Purpose of the Study:
- To quantify endogenous interferon (IFN) levels in patients with Kyasanur Forest Disease (KFD).
- To correlate IFN levels with the disease phase (acute vs. convalescent) and viremia.
- To characterize the antigenic properties of the endogenous IFN in KFD patients.
Main Methods:
- Serum samples were collected from KFD patients during acute (n=51) and convalescent (n=19) phases.
- Interferon levels were measured using established assays.
- Neutralization studies were performed to determine antigenic similarity of endogenous IFN.
Main Results:
- Significantly higher circulating IFN levels were observed in acute phase sera (GM 216.3 ± 8.7) compared to convalescent phase sera (GM 13.19 ± 1.6).
- Elevated IFN levels were concurrent with the viremic phase of KFD.
- Neutralization assays indicated that the endogenous IFN was antigenically similar to the acid-stable form of IFN-alpha.
Conclusions:
- Endogenous interferon plays a significant role during the acute phase of Kyasanur Forest Disease.
- Interferonemia in KFD patients is linked to the viremic stage of the illness.
- The findings suggest that endogenous IFN-alpha may be involved in the host response to KFD virus infection.